ArticleAmerican journal of translational research2024
Prognostic value of the Controlling Nutritional Status score in patients with newly diagnosed multiple myeloma.
Article in American journal of translational research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Prognostic value of the controlling nutritional status (CONUT) score in patients with diffuse large B-cell lymphoma: a meta-analysis.World journal of surgical oncology · 2025Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThere is some evidence indicating that the Controlling Nutritional Status (CONUT) score is a prognostic factor in patients with hematological malignancies, including multiple myeloma (MM). The aim of this study was to assess the prognostic value of the CONUT score in newly diagnosed MM.
methodWe retrospectively investigated multiple clinical variables, including the CONUT score, age, sex, body mass index, M protein type, International Staging System (ISS) stage, Durie-Salmon (DS) stage, and blood cell count, in 58 patients with newly diagnosed MM.
resultThere was a significant correlation between a high CONUT score (>5.5) and poor OS. The prognostic impact of this score was more significant in patients with a low ISS or DS stage. In univariate analysis, the white blood cell count (P=0.021), monocyte count (P=0.022), eosinophil count (P=0.004), and lactic dehydrogenase (LDH) (P=0.042) predicted OS. Multivariate analysis identified the CONUT score (P=0.012), monocyte count (P=0.008), eosinophil count (P=0.031), and LDH (P=0.001) to be independent prognostic factors for overall survival (OS).
conclusionThe CONUT score is a useful prognostic indicator in patients with MM, especially those with a low ISS or DS stage. The monocyte count, eosinophil count, and LDH are independent prognostic factors in these patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.